Literature DB >> 8940484

Evaluations of enzyme-linked immunosorbent assay procedure for determining specific Epstein-Barr virus serology and of rapid test kits for diagnosis for infectious mononucleosis.

M A Gerber1, E D Shapiro, R W Ryan, G L Bell.   

Abstract

Using the results of Epstein-Barr virus-specific immunofluorescence serology as the "gold standard," we found that the sensitivities of the five rapid test kits varied from 78 to 84% and specificities varied from 89 to 100%. Enzyme-linked immunosorbent assay-determined specific Epstein-Barr virus antibody profiles had a sensitivity and specificity of 98.6 and 95.5%, respectively.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8940484      PMCID： PMC229495          DOI： 10.1128/jcm.34.12.3240-3241.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Incidence of heterophil antibody responses in children with infectious mononucleosis.

Authors:  G Fleisher; E T Lennette; G Henle; W Henle
Journal:  J Pediatr       Date:  1979-05       Impact factor: 4.406

2.  A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody.

Authors:  A S Evans; J C Niederman; L C Cenabre; B West; V A Richards
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

Review 3.  Epstein-Barr virus specific diagnostic tests in infectious mononucleosis.

Authors:  W Henle; G E Henle; C A Horwitz
Journal:  Hum Pathol       Date:  1974-09       Impact factor: 3.466

4.  Rapid detection of infectious mononucleosis-associated heterophile antibodies by a novel immunochromatographic assay and a latex agglutination test.

Authors:  S E Farhat; S Finn; R Chua; B Smith; A E Simor; P George; B B Diena; D Diena; M Skulnick
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

5.  Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses.

Authors:  C V Sumaya; Y Ench
Journal:  Pediatrics       Date:  1985-06       Impact factor: 7.124

6.  The rapid diagnosis of infectious mononucleosis using an ELISA that detects IgM antibody to a peptide component of Epstein-Barr virus nuclear antigen.

Authors:  M J Levin; M P Weinstein; C V Sumaya; M Gooch; M Osband; G Rhodes; A M Ackley; C G Wren; J K Podgore
Journal:  Diagn Microbiol Infect Dis       Date:  1991 Jul-Aug       Impact factor: 2.803

7.  False positive EBNA IgM and IgG antibody tests for infectious mononucleosis in children.

Authors:  D Levine; R C Tilton; M F Parry; R Klenk; A Morelli; N Hofreuter
Journal:  Pediatrics       Date:  1994-12       Impact factor: 7.124

8.  The rapid serological diagnosis of infectious mononucleosis.

Authors:  J J Gray; J Caldwell; M Sillis
Journal:  J Infect       Date:  1992-07       Impact factor: 6.072

9.  Comparative evaluation of nine kits for rapid diagnosis of infectious mononucleosis and Epstein-Barr virus-specific serology.

Authors:  M Linderholm; J Boman; P Juto; A Linde
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

10.  Comparative evaluation of three commercial tests for detection of heterophile antibody in patients with infectious mononucleosis.

Authors:  R C Tilton; F Dias; R W Ryan
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948
View more
  3 in total

1.  False-positive result provided by rapid heterophile antibody test in a case of acute infection with hepatitis E virus.

Authors:  Benjamin A C Fisher; Sundeept Bhalara
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 2.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

3.  Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.

Authors:  J S Klutts; R S Liao; W M Dunne; A M Gronowski
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.